Physician profile
Kevin Bailey
NPI 1730613688
$27,896.28
in general payments reported to CMS, 2019-2025
12 companies · $233 in 2025
The $233 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $60.37 · 2021: $1,232 · 2022: $24K · 2023: $2,070 · 2024: $604 · 2025: $233.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,773 · Travel and Lodging: $1,134.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,772.54 |
| Travel and Lodging | $1,133.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $20,608.96 | 2022-2023 | |
| Mid-Atlantic Surgical Systems, LLC | $4,044.16 | 2022-2025 | |
| Rock Medical Orthopedics, INC. | $1,775.88 | 2019-2023 | |
| Stryker Corporation | $729.18 | 2022-2025 | Blueprint Patient Specific Instrumentation, Aequalis Perform Reversed, Accolade |
| Biotissue Holdings INC. | $288.00 | 2024 | |
| Zimmer Biomet Holdings, INC. | $163.22 | 2023-2024 | Tapestry |
| Organogenesis INC. | $79.94 | 2025 | Puraply Wound Matrix, Puraforce |
| Nexus Medical Technologies LLC | $71.58 | 2024-2025 | |
| Vericel Corporation | $57.74 | 2023-2025 | Maci |
| Pacira Pharmaceuticals Incorporated | $37.66 | 2023-2024 | Exparel, Zilretta, Iovera |
| Radius Health, INC. | $23.15 | 2025 | Tymlos |
| Vertex Pharmaceuticals Incorporated | $16.81 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Bailey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.